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ABSTRACT
Prediction of Activity Spectra for Substances (PASS), a new computer program, has been generated to evaluate the
biological activity of four  major flavanoids from a medicinal herb, Boesenbergia pandurata Holtt. (Zingiberaceae).
Principal anti-HIV  and other biological activities of   pinostrobin, pinocembrin, cardamonin and alpinetin were
predicted through PASS, their similarity and difference in the mechanisms of action with reference to accessory
biological activities have been  compared (Tables 1-4) and verified with the available data
(http://195.178.207.233/PASS/socket1.php.) on pharmacological and toxicological activity of these compounds. 
KEY WORDS:  Anti-HIV Drugs, Flavanoids, Boesenbergia pandurata,  Pinostrobin, Pinocembrin, Cardamonin,
Alpinetin.
INTRODUCTION
Acquired immunodeficiency syndrome (AIDS) has evolved rapidly into an epidemic and world-wide health crisis.
The number of people infected with HIV rose to just over 40 million in 2006, an increase of over 2 million since
2004 (WHO/UNAIDS (2006). More than 60% of infected people live in sub-Saharan Africa, where at least 2 million
deaths from HIV/AIDS occurred in 2006. Novel therapeutic strategies are urgently needed for deployment alongside
conventional antiretroviral drugs, vaccines, and microbicides to prevent the spread of the disease.
Many attempts have been carried out to discover compounds as anti-HIV-1 agents and enzyme inhibitors of the
HIV-1. However, the effective agents for treatment of this disease are still in demand since HIV-1 is resistant to
some synthetic anti-HIV-1 PR inhibitors (Borman et al., 1996). HIV-1 PR hydrolyzes viral polyproteins into
functional enzymes and structural proteins that are essential for viral assembly (Kohl et al., 1988). Therefore, HIV-1
PR is considered to be an important target for development of anti-HIV-1 drugs.
A number plants have exhibited a potent anti HIV-1 effect and their valid utilization for the formulation of such
drugs  have been reported during recent past and several active plant based secondary metabolites have been
recognized.  Most of them able to act specifically on enzymatic targets. Different parts of twelve Thai medicinal
plants -  Zingiber zerumbet (rhizome), Boesenburgia pandurata (rhizome), Piper chaba (fruit), Eclipta prostrate
(whole plant), Barleria lupulina (leaf, stem), Acanthus ilicifolius (leaf and stem), Alpinia galangal (rhizome), Piper
betel (leaf), Spilanthes acmella (whole plant), and Coccinia grandis (leaf) have been reported to have a potent HIV-
1 PR  inhibitory activities (Tewtrakul et al.,  2003). Moreover, Tewtrakul et al., (2003) reported that four major
flavoniods (pinostrobin, pinocembrin, cardamonin and alpinetin) isolated from the ethanol extract of Boesenbergia
pandurata (yellow rhizome) to show inhibitory activity against HIV-1 protease (HIV-PR).
Recently, Computer Aided Drug Design (CADD) is widely used in new drug R & D (Franke and Herrmann, 1994). 
Such a newly developed computerized system -  PASS (Prediction of Activity Spectra for Substance) that estimates
simultaneously the probability of more than 100 pharmacological activity, effects and mechanisms (Filimonov et al.,
 1995, Filimonov and Poroikov (1996). Therefore, the present study was designed towards the Prediction of Activity
Spectra for four flavoniod constituents viz;  pinostrobin, pinocembrin, cardamonin and alpinetin.  A specific server
has been generated which predicts the possibility of a drug to be active against a target based on the physico-
chemical methods using comparisons and several algorithms. It is observed that the approach, used in PASS, may be
applied to other biological activities (Filimonov et al.,1995; Filimonov et al.,1996).
MATERIALS AND METHODS
PASS 4.20 prediction search includes 9314 biologically active substances. PASS 4.20 predicts the probabilities of
presence/absence for 114 biological actions simultaneously (main and side pharmacological effects, mechanisms,
specific toxicity). The biological activity spectrum of PASS was designed and prediction was made with the
comparison from the source data available in http://195.178.207.233/PASS/predict.php. Biological activity spectrum
of a compound presents exhibit its activity despite the difference in essential conditions of its  experimental
determination.
RESULTS AND DISCUSSION
Four flavonoids constituents like pinostrobin, pinocembrin, cardamonin and alpinetin were predicted.  PASS
predicted search results shows that  the available information on the pharmacological and toxicological activity of
these compounds and are corroborative with the previous reports (Tewtrakul et al., 2003). The results showed that
pinocembrin could possess several biological activities including anti-HIV(throughtheserver)   
http://195.178.207.233/PASS/socket1.php, (Table-1). More interestingly, this compound showed antineoplastic,
antiseborrheic, and activity against membrane permeability inhibitor.  Next active constituent of the plant extract i.e.,
alpinetine was predicted with such a similar multitude activity through the same server -    
http://195.178.207.233/PASS/socket1.php (Table.2). Pinostrobin was predicted with numerous biological activities
principally with anti-HIV (Table.3) and other accessory activities like
membrane integrity agonist, phosphatase inhibitor, free radical scavenger, apoptosis agonist, cell adhesion inhibitor,
testosterone 17beta-dehydrogenase inhibitor and  antineurotoxic activity
(http://195.178.207.233/PASS/socket1.php). The extended PASS prediction strategy was revealed with an
interesting data yield regarding the biological activities  of cardamonin like antiseborrheic and arminative, etc.,
(Table.4) other than the anti-HIV effects  (http://195.178.207.233/PASS/socket1.php.). After having a  biological
activity prediction, a comparative analysis was made regarding the individual mechanism of action of  these four
active flavanoids of  this plant extract. Controversially, four active flavanoids have shown much variability despite
their similarity in their inhibitory activities (Tables 1-4). This difference may be due to the diversity among the
target sites and the reciprocal activity of the specific drug towards such diversified targets and their differential
physiological conditions too.
CONCLUSION
All the four flavanoids observed to have a multi potentials as hepatoprotectant, antipruritic, allergic, anti-
inflammatory, neuroprotector other than their principal anti-HIV activity.
While planning experiments and choosing the activities on which the compound has to be tested, it is necessary to
keep in mind the balance between the novelty of pharmacological action and the risk to obtain negative result in
experimental testing. Certainly, in this present study, such a vital approach has been made to take into account the
particular interest in some kinds of activities other than the principal anti- HIV activity of the four flavanoids from
this plant extract. The accuracy of biological activity prediction through PASS with reference to four flavanoid
constituents is about 90%.  Moreover, a thorough study regarding the legend, mode of action of the drugs with
reference to the specific targets, their differential physiological conditions need to be mooted up to arrive with a
final design of life saving drugs of this kind.
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Table-1: Biological Activity Spectrum Of Anti HIV constituent - Pinocembrin
28 Substructure descriptors; 0 new. 9
Possible activities at Pa > 70% Pa Pi for Activity:
0,901   0,005    Antineoplastic (brain cancer) 
0,900   0,013    Antiseborrheic 
0,764   0,007    Membrane permeability inhibitor
0,754   0,009    2,6-Dihydroxypyridine 3-monooxygenase inhibitor
0,802   0,061    Membrane integrity agonist 
0,751   0,021    Pulmonary hypertension treatment 
0,736   0,007    Nerve growth factor agonist 
0,716   0,010    Neurotrophic factor enhancer 
0,736   0,035    Cardiovascular analeptic 
EFFECTS
0,802   0,007           Antiviral 
0,802   0,007           Antiviral (HIV)
0,802   0,061           Membrane integrity agonist
0,764   0,007           Membrane permeability inhibitor
0,802   0,061           Membrane integrity agonist 
0,764   0,007           Antitoxic
0,764   0,007           Hepatoprotectant
0,764   0,007           Membrane permeability inhibitor
0,802   0,007           Antipruritic
0,764   0,007           Antipruritic, allergic
0,764   0,007           Membrane permeability inhibitor 
0,802   0,061           Membrane integrity agonist
0,802   0,007           Antiinflammatory 
0,802   0,061           Membrane integrity agonist
0,764   0,007           Membrane permeability inhibitor
0,764   0,007           Neuroprotector
0,764   0,007           Membrane permeability inhibitor 
0,736   0,007           Nerve growth factor agonist 
0,736   0,007           Antiparkinsonian 
0,736   0,007           Nerve growth factor agonist
0,736   0,035           Analeptic 
0,736   0,035           Cardiovascular analeptic 
0,736   0,007           Cognition disorders treatment 
0,736   0,007           Alzheimer's disease treatment 
0,736   0,007           Nerve growth factor agonist
0,716   0,010           Neurotrophic factor enhancer
0,736   0,007           Nerve growth factor agonist
0,716   0,010           Neurotrophic factor enhancer 
0,900   0,013           Dermatologic 
0,802   0,061           Antieczematic
0,802   0,061           Membrane integrity agonist
0,900   0,013           Antiseborrheic
0,802   0,061           Membrane integrity agonist
0,764   0,007           Hemostatic
0,764   0,007           Membrane permeability inhibitor
0,802   0,007           Psychotropic 
0,736   0,007           Nootropic
0,736   0,007           Nerve growth factor agonist 
0,802   0,061           Antiepileptic
0,802   0,061           Membrane integrity agonist
0,764   0,007           Vasoprotector 
0,764   0,007           Membrane permeability inhibitor
0,736   0,007           Antiischemic, cerebral 
0,736   0,007           Nerve growth factor agonist 
0,736   0,007           Amyotrophic lateral sclerosis treatment 
0,736   0,007           Nerve growth factor agonist
0,764   0,007           Septic shock treatment 
0,764   0,007           Membrane permeability inhibitor
0,901   0,005           Antineoplastic (brain cancer)
0,751   0,021           Pulmonary hypertension treatment 
MECHANISMS
0,764   0,007           Membrane permeability inhibitor
0,754   0,009           2,6-Dihydroxypyridine 3-monooxygenase inhibitor
0,802   0,061           Membrane integrity agonist
0,900   0,013           Antiseborrheic 
0,736   0,007           Nerve growth factor agonist 
0,716   0,010           Neurotrophic factor enhancer 
0,736   0,035           Cardiovascular analeptic 
 
Table-2: Biological Activity Spectrum Of Anti HIV constituent - Alpinetine
22 Substructure descriptors; 0 new. 19 Possible activities at Pa > 70% Pa Pi for
Activity:
0,935   0,007    Membrane integrity agonist 
0,858   0,024    Mucomembranous protector 
0,821   0,011    Antineurotoxic 
0,811   0,004    NAD(P)H dehydrogenase (quinone) inhibitor
0,802   0,004    Capillary fragility treatment 
0,799   0,013    Membrane integrity antagonist 
0,761   0,005    Cytochrome P450 inhibitor 
0,761   0,006    Free radical scavenger 
0,762   0,011    Apoptosis agonist 
0,747   0,003    Testosterone 17beta-dehydrogenase inhibitor
0,745   0,006    Cell adhesion inhibitor
0,736   0,001    Leucoanthocyanidin reductase inhibitor
0,742   0,007    CYP2A11 substrate 
0,732   0,003    Naringenin-chalcone synthase inhibitor 
0,745   0,016    Pectate lyase inhibitor 
0,712   0,007    Scytalone dehydratase inhibitor
0,704   0,004    Iodide peroxidase inhibitor
0,761   0,061    Phosphatase inhibitor 
0,702   0,015    Carbonyl reductase (NADPH) inhibitor 
EFFECTS
0,935   0,007           Antiviral
0,935   0,007           Antiviral (HIV) 
0,935   0,007           Membrane integrity agonist
0,935   0,007           Membrane integrity agonist
0,799   0,013           Membrane integrity antagonist
0,799   0,013           Antiprotozoal 
0,799   0,013           Membrane integrity antagonist 
0,821   0,006           Antitoxic
0,821   0,011           Antineurotoxic 
0,761   0,006           Hepatoprotectant 
0,761   0,006           Free radical scavenger 
0,935   0,005           Antipruritic 
0,761   0,006           Antieczematic atopic
0,761   0,006           Free radical scavenger
0,761   0,005           Antipruritic, allergic 
0,761   0,006           Free radical scavenger
0,761   0,005           Cytochrome P450 inhibitor 
0,935   0,007           Membrane integrity agonist
0,761   0,061           Antidiabetic
0,761   0,061           Phosphatase inhibitor 
0,935   0,006           Antiinflammatory 
0,935   0,007           Membrane integrity agonist
0,761   0,006           Free radical scavenger 
0,799   0,013           Antineoplastic 
0,799   0,013           Membrane integrity antagonist
0,761   0,061           Phosphatase inhibitor
0,761   0,006           Neuroprotector
0,761   0,006           Free radical scavenger 
0,799   0,013           Anesthetic
0,799   0,013           Membrane integrity antagonist
0,799   0,013           Antifungal
0,799   0,013           Membrane integrity antagonist
0,935   0,006           Antiischemic 
0,761   0,006           Antiischemic, cerebral 
0,761   0,006           Free radical scavenger
0,935   0,007           Antiischemic renal
0,935   0,007           Membrane integrity agonist 
0,761   0,006           Free radical scavenger 
0,935   0,006           Dermatologic 
0,761   0,006           Antipsoriatic
0,761   0,006           Free radical scavenger 
0,935   0,006           Antieczematic 
0,935   0,007           Membrane integrity agonist
0,761   0,006           Free radical scavenger
0,935   0,007           Antiseborrheic 
0,935   0,007           Membrane integrity agonist
0,935   0,006           Psychotropic
0,761   0,006           Nootropic 
0,761   0,006           Alzheimer's disease treatment
0,761   0,006           Free radical scavenger
0,761   0,006           Free radical scavenger 
0,935   0,007           Antiepileptic
0,935   0,007           Membrane integrity agonist
0,799   0,013           Antibiotic
0,799   0,013           Membrane integrity antagonist
0,799   0,013           Antiarrhythmic 
0,799   0,013           Membrane integrity antagonist
0,761   0,005           Prostate cancer treatment 
0,761   0,005           Cytochrome P450 inhibitor 
0,858   0,024           Antiulcerative
0,858   0,024           Mucomembranous protector
0,799   0,013           Contraceptive female
0,799   0,013           Membrane integrity antagonist
0,762   0,011           Apoptosis agonist
0,745   0,006           Cell adhesion inhibitor 
0,802   0,004           Capillary fragility treatment 
MECHANISMS
0,935   0,007           Membrane integrity agonist
0,858   0,024           Mucomembranous protector
0,811   0,004           NAD(P)H dehydrogenase (quinone) inhibitor
0,799   0,013           Membrane integrity antagonist 
0,761   0,005           Cytochrome P450 inhibitor 
0,761   0,006           Free radical scavenger 
0,747   0,003           Testosterone 17beta-dehydrogenase inhibitor
0,745   0,006           Cell adhesion inhibitor
0,736   0,001           Leucoanthocyanidin reductase inhibitor 
0,742   0,007           CYP2A11 substrate 
0,732   0,003           Naringenin-chalcone synthase inhibitor
0,745   0,016           Pectate lyase inhibitor
0,712   0,007           Scytalone dehydratase inhibitor 
0,704   0,004           Iodide peroxidase inhibitor
0,761   0,061           Phosphatase inhibitor 







Table-3: Biological Activity Spectrum Of Anti HIV constituent - Pinostrobin
32 Substructure descriptors; 0 new. 237 Possible activities at Pa > 30% Pa Pi for Activity:
0,939   0,007    Membrane integrity agonist
0,857   0,020    Phosphatase inhibitor
0,793   0,005    Free radical scavenger
0,770   0,010    Apoptosis agonist
0,752   0,006    Cell adhesion inhibitor
0,745   0,003    Testosterone 17beta-dehydrogenase inhibitor
0,758   0,020    Antineurotoxic 
0,771   0,048    Mucomembranous protector 
0,727   0,006    Cytochrome P450 inhibitor 
0,717   0,004    Naringenin-chalcone synthase inhibitor
0,732   0,019    Pectate lyase inhibitor 
0,725   0,023    Membrane integrity antagonist
0,710   0,007    Naringenin 3-dioxygenase inhibitor
0,703   0,006    Antioxidant 0,698   0,016    L-ascorbate oxidase inhibitor
0,685   0,004    Iodide peroxidase inhibitor 
0,685   0,005    Capillary fragility treatment 
0,693   0,014    Membrane permeability inhibitor
0,683   0,006    NAD(P)H dehydrogenase (quinone) inhibitor
0,670   0,001    Leucoanthocyanidin reductase inhibitor
0,656   0,014    P-benzoquinone reductase (NADPH) inhibitor 
0,640   0,005    Creatine kinase inhibitor 
0,653   0,026    Carbonyl reductase (NADPH) inhibitor
0,694   0,083    Myocardial ischemia treatment 
0,613   0,005    Chemopreventive 
0,610   0,006    Phenylalanine ammonia-lyase inhibitor
0,614   0,012    CYP1A substrate 
0,630   0,033    Neurotrophic factor enhancer 
0,583   0,011    Caffeate O-methyltransferase inhibitor 
0,589   0,029    Emetic 
0,620   0,064    Nerve growth factor agonist 
0,570   0,018    Aryl-alcohol dehydrogenase (NADP+) inhibitor
0,612   0,069    NAD(P)+-arginine ADP-ribosyltransferase inhibitor
0,546   0,004    Antihemorrhagic 
0,575   0,040    1-Alkylglycerophosphocholine O-acetyltransferase inhibitor
0,591   0,072    Fibrinolytic 
0,537   0,023    CYP2A11 substrate
0,663   0,153    Antiseborrheic 
0,556   0,046    CYP2A3 substrate
0,562   0,060    Antidyskinetic 
0,523   0,021    Beta-carotene 15,15'-monooxygenase inhibitor
0,522   0,022    Antiviral (Herpes)
0,535   0,036    Histamine release stimulant
0,532   0,034    CDK2/cyclin A inhibitor
0,536   0,041    Antiinflammatory
0,509   0,015    Lipid peroxidase inhibitor
0,533   0,042    NADPH-ferrihemoprotein reductase inhibitor
0,504   0,015    CYP1A1 substrate
0,529   0,046    Cytochrome P450 CYP2C9 inhibitor
0,497   0,023    5 Lipoxygenase inhibitor
0,508   0,035    Dihydroxy-acid dehydratase inhibitor 
0,474   0,002    Cytochrome P450 CYP3A4 inhibitor 
0,482   0,010    Glutathione-disulfide reductase inhibitor 
0,558   0,096    Oxidoreductase inhibitor
0,503   0,040    Kinase inhibitor 
0,485   0,025    Hepatoprotectant 
0,495   0,038    Carminative
0,507   0,058    Antineoplastic 
0,543   0,094    Hydroxylamine reductase (NADH) inhibitor 
0,468   0,030    CYP1A2 substrate 
0,466   0,031    Hemostatic
0,465   0,033    Scytalone dehydratase inhibitor
0,444   0,013    Osteoarthritis treatment
0,508   0,082    Trans-cinnamate 4-monooxygenase inhibitor
0,469   0,044    Nephrotoxic 
0,448   0,023    Reductant 
0,464   0,043    CYP2C11 substrate 
0,488   0,068    Nitrite reductase [NAD(P)H] inhibitor
0,498   0,080    Steroid N-acetylglucosaminyltransferase inhibitor 
0,592   0,178    Cardioprotectant 
0,430   0,023    Sweetener 
0,434   0,031    Hepatic disorders treatment 
0,446   0,049    Polarisation stimulant 
0,495   0,100    CYP3A2 substrate
0,399   0,007    Histidine decarboxylase inhibitor
0,425   0,034    Xenobiotic-transporting ATPase inhibitor 
0,449   0,059    Histamine release inhibitor
0,394   0,005    CYP1B substrate 
0,401   0,013    Epoxide hydrolase inhibitor
0,482   0,096    Trans-pentaprenyltranstransferase inhibitor
0,416   0,031    Plastoquinol-plastocyanin reductase inhibitor 
0,517   0,138    CYP3A1 substrate 
0,410   0,036    Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor 
0,395   0,029    Antidiabetic symptomatic 
0,370   0,005    CYP1B1 substrate 
0,423   0,058    Vitamin-K-epoxide reductase (warfarin-insensitive) inhibitor 
0,379   0,017    Dihydrobenzophenanthridine oxidase inhibitor
0,412   0,051    Analeptic 
0,409   0,049    Trypanothione-disulfide reductase inhibitor 
0,369   0,013    Quercetin 2,3-dioxygenase inhibitor 
0,440   0,084    CYP2B5 substrate 
0,437   0,082    Bilirubin oxidase inhibitor 
0,361   0,010    Expectorant 
0,379   0,029    Flavone apiosyltransferase inhibitor
0,446   0,095    Toxic 
0,375   0,028    2-Enoate reductase inhibitor 
0,476   0,129    Cardiovascular analeptic 
0,378   0,031    Narcotic 
0,373   0,028    Myc inhibitor 
0,517   0,172    Ecdysone 20-monooxygenase inhibitor
0,438   0,097    Gonadotropin antagonist
0,356   0,016    (S)-canadine synthase inhibitor 
0,389   0,051    Cytostatic
0,365   0,027    Imidazoline I1 receptor agonist
0,387   0,050    L-lysine 6-transaminase inhibitor 
0,436   0,099    Membrane permeability enhancer
0,377   0,042    Antidote 
0,382   0,050    CYP2C6 substrate
0,381   0,050    DNA ligase (ATP) inhibitor
0,380   0,053    Asparagine-tRNA ligase inhibitor 
0,442   0,115    Indole-3-acetaldehyde oxidase inhibitor 
0,401   0,074    Cholestanetriol 26-monooxygenase inhibitor
 0,382   0,060    Antifungal
 0,432   0,111    4-Methoxybenzoate monooxygenase (O-demethylating) inhibitor 
0,376   0,060    Antiulcerative 
0,419   0,107    Antipruritic 
0,400   0,088    Psychosexual dysfunction treatment 
0,426   0,114    CYP2A2 substrate 
0,318   0,009    Mucolytic 
0,333   0,025    Salutaridinol 7-O-acetyltransferase inhibitor 
0,439   0,132    Leukotriene C antagonist
0,406   0,100    2,6-Dihydroxypyridine 3-monooxygenase inhibitor
0,371   0,067    Phenol 2-monooxygenase inhibitor
0,402   0,098    CYP2B11 substrate
0,412   0,109    Immunosuppressant 
0,371   0,071    CYP2A5 substrate 
0,331   0,030    Indoleamine-pyrrole 2,3-dioxygenase inhibitor
0,375   0,075    CYP2F1 substrate
0,374   0,074    Inositol 4-methyltransferase inhibitor
0,398   0,099    Nitrate reductase inhibitor
0,371   0,073    Thiamine-triphosphatase inhibitor 
0,313   0,014    Tubulin antagonist 
0,312   0,015    Glycerol dehydrogenase (NADP+) inhibitor
0,440   0,147    Adenylate cyclase stimulant 
0,302   0,013    2-Dehydropantolactone reductase (A-specific) inhibitor 
0,326   0,038    Deoxyribonuclease I inhibitor 
0,314   0,026    CYP2A10 substrate 
0,430   0,144    Proteasome endopeptidase complex inhibitor
0,322   0,035    3-Demethylubiquinone-9 3-O-methyltransferase inhibitor 
0,352   0,066    Respiratory analeptic 
0,389   0,104    Antipsoriatic 
0,399   0,113    Hypothermic 
0,368   0,089    Carcinogenic, male rats 
0,327   0,049    RNA synthesis inhibitor 
0,301   0,026    Lipoxygenase inhibitor
0,495   0,223    Hematotoxic
0,332   0,069    Interferon antagonist
0,321   0,060    Contraceptive 
0,319   0,058    Bronchodilator 
0,308   0,048    Imidazoline receptor agonist
0,315   0,056    Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase inhibitor 
0,315   0,058    Contraceptive female 
0,331   0,074    Phloroglucinol reductase inhibitor 
0,387   0,131    L-glucuronate reductase inhibitor 
0,326   0,071    Fumarate reductase (NADH) inhibitor 
0,380   0,127    Alcohol oxidase inhibitor
0,330   0,083    Antineoplastic (multiple myeloma)
0,394   0,147    Thromboxane B2 antagonist
0,352   0,106    CYP3A4 substrate 
0,304   0,061    Tetrahydroxynaphthalene reductase inhibitor
0,390   0,147    Antialcoholic 
0,388   0,149    Antitoxic 
0,306   0,067    Biphenyl-2,3-diol 1,2-dioxygenase inhibitor
0,304   0,069    Antiosteoporotic 
0,398   0,163    Neurotrophic factor 
0,350   0,117    Miotic 
0,426   0,194    Peroxidase inhibitor
0,390   0,158    Antipruritic, allergic 
0,375   0,145    Teratogen 
0,319   0,091    Anorexiant 
0,382   0,155    Glucan 1,4-beta-glucosidase inhibitor
0,395   0,171    Cyclooxygenase 1 inhibitor
0,303   0,079    AMP deaminase inhibitor 
0,359   0,137    Prostaglandin antagonist 
0,361   0,140    Chemoprotective 
0,312   0,094    Hypertensive 
0,326   0,108    CYP3A substrate 
0,340   0,122    Gentisate 1,2-dioxygenase inhibitor
0,410   0,195    Tumour necrosis factor alpha antagonist 
0,394   0,179    Cathepsin G inhibitor 
0,384   0,172    Lactaldehyde reductase inhibitor 
0,392   0,181    Quinoprotein glucose dehydrogenase inhibitor 
0,366   0,158    Interferon agonist 
0,319   0,118    Anthranilate 3-monooxygenase (deaminating) inhibitor 
0,349   0,150    Dermatologic
0,342   0,145    Pulmonary hypertension treatment
0,377   0,182    Magnesium-
protoporphyrin IX monomethyl ester (oxidative) cyclase inhibitor 
0,341   0,152    H+-transporting two-sector ATPase inhibitor 
0,399   0,213    CYP2D16 substrate 
0,355   0,171     Pyruvate decarboxylase inhibitor
0,361   0,179    Antihelmintic (Nematodes) 
0,391   0,218    CYP2A1 substrate 
0,310   0,142    Antileukemic 
0,306   0,139    Monoamine uptake inhibitor 
0,386   0,221    Lipid metabolism regulator 
0,366   0,203    Penicillin amidase inhibitor 
0,321   0,162    Octopamine antagonist
0,337   0,178    Antineoplastic (solid tumors)
0,316   0,161    Glutaminase inhibitor 
0,329   0,177    Glycerol-3-phosphate dehydrogenase inhibitor 
0,351   0,202    Antineoplastic (brain cancer)
0,313   0,166    CYP2C8 substrate
0,327   0,180    Atherosclerosis treatment
0,326   0,183    L-iditol 2-dehydrogenase inhibitor 
0,314   0,175    Microtubule formation stimulant 
0,311   0,177    CYP2B6 substrate
0,308   0,212    Myosin ATPase inhibitor 
0,333   0,243    ATPase inhibitor 
0,311   0,222    Antiinflammatory, ophthalmic
0,360   0,277    Uroporphyrinogen-III synthase inhibitor
0,323   0,243    Dependence treatment
0,302   0,225    Ovulation inhibitor 
0,319   0,245    Platelet adhesion inhibitor 
0,337   0,264    Vasodilator, cerebral
0,340   0,268    Leukotriene C4 antagonist 
0,311   0,240    CC chemokine 2 receptor antagonist 
0,301   0,230    Laccase inhibitor 
0,306   0,236    Vomilenine glucosyltransferase inhibitor
0,362   0,296    Antihypoxic 
0,349   0,287    Cystic fibrosis treatment 
0,321   0,263    Membrane dipeptidase inhibitor 
0,316   0,259    Lysase inhibitor
0,329   0,289    2-Oxoglutarate decarboxylase inhibitor 
0,335   0,301    Glyceryl-ether monooxygenase inhibitor 
0,343   0,311    NADPH oxidase inhibitor 
0,350   0,324    Cardiotoxic 
0,324   0,301    3-Hydroxybenzoate 4-monooxygenase inhibitor 
0,322   0,299    Monodehydroascorbate reductase (NADH) inhibitor
0,335   0,316    Insulysin inhibitor 
0,321   0,304    Integrin antagonist 
0,301   0,291    Gingipain K inhibitor
0,302   0,300    [acyl-carrier-protein] S-acetyltransferase inhibitor
0,327   0,328    General pump inhibitor
0,305   0,312    2,3-Dihydroxybenzoate 2,3-dioxygenase inhibitor 
0,303   0,319    Convulsant 
0,309   0,328    N-carbamoyl-L-amino-acid hydrolase inhibitor 
0,313   0,332    Chitinase inhibitor 
 
EFFECTS
0,939   0,007           Antiviral
0,522   0,022           Antiviral (Herpes) 
0,367   0,158           Antiviral (Hepatitis)
0,367   0,158           Interferon agonist 
0,939   0,007           Antiviral (HIV) 
0,939   0,007           Membrane integrity agonist
0,701   0,014           Membrane permeability inhibitor 
0,939   0,007           Membrane integrity agonist 
0,727   0,023           Membrane integrity antagonist 
0,438   0,099           Membrane permeability enhancer 
0,367   0,158           Interferon agonist 
0,332   0,049           RNA synthesis inhibitor
0,727   0,023           Antiprotozoal
0,727   0,023           Membrane integrity antagonist 
0,438   0,099           Membrane permeability enhancer 
0,564   0,010           Antitussive 
0,564   0,010           Expectorant
0,727   0,023           Antibacterial
0,727   0,023           Antibiotic
0,727   0,023           Membrane integrity antagonist
0,438   0,099           Membrane permeability enhancer
0,438   0,099           Antimycobacterial 
0,438   0,099           Membrane permeability enhancer
0,438   0,099           Membrane permeability enhancer
0,797   0,005           Antitoxic
0,758   0,020           Antineurotoxic 
0,797   0,005           Hepatoprotectant
0,485   0,025           Liver fibrosis treatment 
0,797   0,005           Hepatoprotectant 
0,797   0,005           Free radical scavenger 
0,701   0,014           Membrane permeability inhibitor 
0,939   0,005           Antipruritic 
0,684   0,026           Allergic conjunctivitis treatment 
0,684   0,026           Lipoxygenase inhibitor 
0,939   0,005           Antipruritic
0,646   0,107           Antiacne 
0,939   0,005           Antipruritic 
0,797   0,005           Antieczematic atopic
0,797   0,005            Free radical scavenger 
0,939   0,005           Antipruritic 
0,507   0,109           Immunosuppressant
0,797   0,005           Antipruritic, allergic 
0,797   0,005           Free radical scavenger 
0,728   0,006           Cytochrome P450 inhibitor 
0,701   0,014           Membrane permeability inhibitor
0,523   0,023           5 Lipoxygenase inhibitor 
0,507   0,109           Immunosuppressant 
0,400   0,007           Histidine decarboxylase inhibitor 
0,646   0,107           Antipruritic, non-allergic 
0,939   0,005           Antipruritic 
0,939   0,007           Membrane integrity agonist 
0,386   0,221           Hypolipemic 
0,386   0,221           Lipid metabolism regulator 
0,857   0,020           Antidiabetic 
0,395   0,029           Antidiabetic symptomatic 
0,857   0,020           Phosphatase inhibitor 
0,727   0,023           Cardiotonic 
0,727   0,023           Antiarrhythmic
0,727   0,023           Membrane integrity antagonist 
0,440   0,027           Heart failure treatment
0,440   0,147           Adenylate cyclase stimulant
0,365   0,027           Imidazoline I1 receptor agonist 
0,440   0,147           Adenylate cyclase stimulant 
0,939   0,005           Antiinflammatory 
0,311   0,222           Antiinflammatory, ophthalmic 
0,939   0,007           Membrane integrity agonist 
0,797   0,005           Free radical scavenger
0,701   0,014           Membrane permeability inhibitor 
0,684   0,026           Lipoxygenase inhibitor 
0,523   0,023           5 Lipoxygenase inhibitor 
0,507   0,109           Immunosuppressant 
0,410   0,195           Tumour necrosis factor alpha antagonist
0,394   0,179           Cathepsin G inhibitor 
0,363   0,137           Prostaglandin antagonist
0,321   0,304           Integrin antagonist 
0,523   0,023           Autoimmune disorders treatment
0,523   0,023           Rheumatoid arthritis treatment 
0,523   0,023           5 Lipoxygenase inhibitor 
0,410   0,195           Tumour necrosis factor alpha antagonist
0,507   0,109            Systemic lupus erythematosus treatment 
0,507   0,109            Immunosuppressant 
0,507   0,109            Multiple sclerosis treatment 
0,507   0,109            Immunosuppressant 
0,367   0,158            Interferon agonist 
0,327   0,328            Radioprotector 
0,327   0,328            General pump inhibitor 
0,857   0,014             Antineoplastic 
0,315   0,014             Antileukemic 
0,315   0,014             Tubulin antagonist 
0,351   0,202             Antineoplastic (brain cancer)
0,315   0,014             Antineoplastic (breast cancer)
0,315   0,014             Tubulin antagonist 
0,315   0,014             Antineoplastic (colorectal cancer)
0,315   0,014             Tubulin antagonist 
0,315   0,014             Antineoplastic (lung cancer) 
0,315   0,014             Tubulin antagonist 
0,330   0,083             Antineoplastic (multiple myeloma) 
0,337   0,178             Antineoplastic (solid tumors)
0,857   0,020             Phosphatase inhibitor 
0,727   0,023             Membrane integrity antagonist 
0,503   0,040             Kinase inhibitor 
0,373   0,028             Myc inhibitor 
0,367   0,158             Interferon agonist 
0,332   0,049             RNA synthesis inhibitor 
0,321   0,304             Integrin antagonist 
0,315   0,014             Tubulin antagonist 
0,314   0,175             Microtubule formation stimulant 
0,797   0,005             Neuroprotector 
0,797   0,005             Free radical scavenger
0,701   0,014             Membrane permmeability inhibitor 
0,620   0,064             Nerve growth factor agonist 
0,575   0,015             Lipid peroxidase inhibitor 
0,438   0,099             Membrane permeability enhancer
0,440   0,099             Ophthalmic drug 
0,440   0,099             Antiglaucomic 
0,440   0,147             Adenylate cyclase stimulant
0,438   0,099             Membrane permeability enhancer
0,727   0,023             Anesthetic
0,727   0,023             Membrane integrity antagonist 
0,620   0,040             Antiparkinsonian
0,620   0,064             Nerve growth factor agonist 
0,503   0,040             Kinase inhibitor 
0,438   0,099            Prostate disorders treatment
0,438   0,099            Membrane permeability enhancer 
0,495   0,044            Toxic 
0,350   0,324            Cardiotoxic 
0,495   0,223            Hematotoxic 
0,469   0,044            Nephrotoxic
0,449   0,059           Analgesic
0,449   0,059            Analgesic, non-opioid
0,449   0,059            Histamine release inhibitor 
0,394   0,147            Thromboxane B2 antagonist 
0,363   0,137            Prostaglandin antagonist
0,365   0,027           Antihypertensive 
0,365   0,027            Imidazoline I1 receptor agonist
0,438   0,099           Antiparasitic 
0,438   0,099            Membrane permeability enhancer 
0,476   0,051           Analeptic 
0,476   0,129            Cardiovascular analeptic 
0,352   0,066            Respiratory analeptic 
0,449   0,007           Antiallergic 
0,449   0,059            Antiallergic rhinitis
0,449   0,059            Histamine release inhibitor 
0,449   0,059            Histamine release inhibitor
0,439   0,132            Leukotriene C antagonist
0,400   0,007            Histidine decarboxylase inhibitor 
0,727   0,023           Antifungal 
0,727   0,023            Membrane integrity antagonist 
0,503   0,040            Kinase inhibitor 
0,438   0,099            Membrane permeability enhancer 
0,367   0,158           Antiinfective 
0,367   0,158            Interferon agonist
0,939   0,005           Antiischemic 
0,797   0,005            Antiischemic, cerebral 
0,797   0,005            Free radical scavenger 
0,620   0,064            Nerve growth factor agonist 
0,575   0,015            Lipid peroxidase inhibitor
0,438   0,099            Membrane permeability enhancer 
0,337   0,264           Vasodilator, cerebral 
0,939   0,007           Antiischemic renal
0,939   0,007           Membrane integrity agonist 
0,694   0,083           Myocardial ischemia treatment 
0,440   0,147           Adenylate cyclase stimulant
0,797   0,005           Free radical scavenger
0,311   0,240           Antineurogenic pain 
0,311   0,240           CC chemokine 2 receptor antagonist 
0,797   0,005           Antioxidant 
0,703   0,006           Acute neurologic disorders treatment 
0,797   0,005           Antioxidant 
0,575   0,015           Lipid peroxidase inhibitor
0,797   0,005           Alzheimer's disease treatment 
0,797   0,005           Free radical scavenger
0,797   0,005           Antioxidant 
0,630   0,033           Neurotrophic factor enhancer 
0,620   0,064           Nerve growth factor agonist 
0,398   0,163           Neurotrophic factor 
0,395   0,171           Cyclooxygenase 1 inhibitor 
0,703   0,006           Amyotrophic lateral sclerosis treatment
0,797   0,005           Antioxidant 
0,620   0,064           Nerve growth factor agonist
0,398   0,163           Neurotrophic factor 
0,575   0,015           Lipid peroxidase inhibitor 
0,368   0,089           Carcinogenic 
0,368   0,089           Carcinogenic, male rats 
0,630   0,033           Cognition disorders treatment 
0,630   0,033           Neurotrophic factor enhancer 
0,620   0,064           Nerve growth factor agonist 
0,398   0,163           Neurotrophic factor 
0,939   0,005           Dermatologic 
0,797   0,005           Antipsoriatic 
0,797   0,005           Free radical scavenger
0,523   0,023           5 Lipoxygenase inhibitor 
0,939   0,005           Antieczematic
0,939   0,007           Membrane integrity agonist
0,797   0,005           Free radical scavenger 
0,507   0,109           Immunosuppressant
0,939   0,007           Antiseborrheic
0,939   0,007           Membrane integrity agonist 
0,701   0,014           Hemostatic
0,466   0,031           Antihemophilic
0,701   0,014           Hemostatic 
0,701   0,014           Membrane permeability inhibitor 
0,939   0,005           Psychotropic 
0,797  0,005            Nootropic
0,797   0,005           Free radical scavenger 
0,640   0,005           Creatine kinase inhibitor 
0,620   0,064           Nerve growth factor agonist
0,438   0,099           Membrane permeability enhancer 
0,939   0,007           Antiepileptic 
0,939   0,007           Membrane integrity agonist 
0,701   0,014           Vasoprotector
0,701   0,014           Membrane permeability inhibitor
0,684   0,023           Antiasthmatic 
0,684   0,026           Lipoxygenase inhibitor
0,523   0,023           5 Lipoxygenase inhibitor 
0,449   0,059           Histamine release inhibitor 
0,439   0,132           Leukotriene C antagonist 
0,410   0,195           Tumour necrosis factor alpha antagonist 
0,340   0,268           Leukotriene C4 antagonist 
0,321   0,304           Integrin antagonist 
0,684   0,023           Antiarthritic 
0,684   0,026           Lipoxygenase inhibitor 
0,523   0,023           5 Lipoxygenase inhibitor
0,507   0,109           Immunosuppressant 
0,311   0,240           CC chemokine 2 receptor antagonist
0,728   0,006           Prostate cancer treatment 
0,728   0,006           Cytochrome P450 inhibitor
0,523   0,023           Inflammatory Bowel disease treatment 
0,523   0,023           5 Lipoxygenase inhibitor 
0,507   0,109           Immunosuppressant 
0,367   0,158           Interferon agonist 
0,321   0,304           Integrin antagonist
0,438   0,099           Antiemetic
0,438   0,099           Membrane permeability enhancer 
0,333   0,069           Antiosteoporotic 
0,333   0,243           ATPase inhibitor 
0,321   0,304           Integrin antagonist 
0,684   0,026           Antithrombotic
0,684   0,026           Lipoxygenase inhibitor
0,440   0,147           Adenylate cyclase stimulant
0,394   0,147           Thromboxane B2 antagonist 
0,321   0,304           Integrin antagonist 
0,319   0,245           Platelet adhesion inhibitor 
0,771   0,048           Antiulcerative 
0,771   0,048           Mucomembranous protector 
0,333   0,243           ATPase inhibitor 
0,727   0,023           Contraceptive female 
0,727   0,023           Membrane integrity antagonist 
0,438   0,099           Cystic fibrosis treatment 
0,438   0,099           Membrane permeability enhancer 
0,438   0,099           Prostatic (benign) hyperplasia treatment
0,438   0,099           Membrane permeability enhancer
0,373   0,028           Restenosis treatment 
0,373   0,028           Myc inhibitor 
0,701   0,014           Septic shock treatment 
0,701   0,014           Membrane permeability inhibitor 
0,363   0,137           Vasodilator, peripheral 
0,363   0,137           Prostaglandin antagonist 
0,770   0,010           Apoptosis agonist 
0,752   0,006           Cell adhesion inhibitor 
0,613   0,005           Chemopreventive
0,444   0,013           Osteoarthritis treatment 
0,448   0,023           Reductant 
0,592   0,178           Cardioprotectant 
0,430   0,023           Sweetener 
0,434   0,031           Hepatic disorders treatment 
0,389   0,051           Cytostatic 
0,377   0,042           Antidote
0,400   0,088           Psychosexual dysfunction treatment 
0,399   0,113           Hypothermic 
0,321   0,060           Contraceptive 
0,375   0,145           Teratogen 
0,319   0,091           Anorexiant 
0,361   0,140           Chemoprotective 
0,312   0,094           Hypertensive 
0,327   0,180           Atherosclerosis treatment
0,362   0,296           Antihypoxic
0,685   0,005           Capillary fragility treatment 
0,546   0,004           Antihemorrhagic
0,591   0,072           Fibrinolytic 
0,562   0,060           Antidyskinetic
0,318   0,009           Mucolytic
0,319   0,058           Bronchodilator
0,390   0,147           Antialcoholic 
0,350   0,117           Miotic 
0,342   0,145           Pulmonary hypertension treatment 
0,361   0,179           Antihelmintic (Nematodes) 
0,323   0,243           Dependence treatment 
0,302   0,225           Ovulation inhibitor 
MECHANISMS
0,939   0,007           Membrane integrity agonist 
0,939   0,007           Antiseborrheic 
0,939   0,005           Antiinflammatory
0,939   0,005           Antipruritic 
0,857   0,020           Phosphatase inhibitor 
0,857   0,014           Antineoplastic
0,797   0,005           Free radical scavenger
0,939   0,005           Antiinflammatory 
0,797   0,005           Hepatoprotectant 
0,797   0,005           Antipruritic, allergic
0,797   0,005           Antipsoriatic 
0,752   0,006           Cell adhesion inhibitor 
0,745   0,003           Testosterone 17beta-dehydrogenase inhibitor 
0,771   0,048           Mucomembranous protector
0,728   0,006           Cytochrome P450 inhibitor 
0,474   0,002           Cytochrome P450 CYP3A4 inhibitor 
0,529   0,046           Cytochrome P450 CYP2C9 inhibitor 
0,797   0,005           Antipruritic, allergic 
0,717   0,004           Naringenin-chalcone synthase inhibitor
0,732   0,019           Pectate lyase inhibitor 
0,727   0,023           Membrane integrity antagonist 
0,857   0,014           Antineoplastic 
0,727   0,023           Antifungal 
0,727   0,023           Contraceptive female 
0,710   0,007           Naringenin 3-dioxygenase inhibitor 
0,797   0,005           Antioxidant 
0,698   0,016           L-ascorbate oxidase inhibitor 
0,685   0,004           Iodide peroxidase inhibitor 
0,701   0,014           Membrane permeability inhibitor
0,939   0,005           Antiinflammatory 
0,797   0,005           Hepatoprotectant 
0,701   0,014           Hemostatic 
0,797   0,005           Antipruritic, allergic 
0,683   0,006           NAD(P)H dehydrogenase (quinone) inhibitor 
0,670   0,001           Leucoanthocyanidin reductase inhibitor 
0,656   0,014           P-benzoquinone reductase (NADPH) inhibitor
0,640   0,005           Creatine kinase inhibitor 
0,653   0,026           Carbonyl reductase (NADPH) inhibitor 
0,610   0,006           Phenylalanine ammonia-lyase inhibitor 
0,614   0,012           CYP1A substrate
0,504   0,015           CYP1A1 substrate
0,468   0,030           CYP1A2 substrate
0,630   0,033           Neurotrophic factor enhancer 
0,583   0,011           Caffeate O-methyltransferase inhibitor
0,620   0,064           Nerve growth factor agonist
0,570   0,018           Aryl-alcohol dehydrogenase (NADP+) inhibitor
0,612   0,069           NAD(P)+-arginine ADP-ribosyltransferase inhibitor
0,575   0,040           1-Alkylglycerophosphocholine O-acetyltransferase inhibitor
0,537   0,023           CYP2A11 substrate 
0,556   0,046           CYP2A3 substrate 
0,523   0,021           Beta-carotene 15,15'-monooxygenase inhibitor 
0,535   0,036           Histamine release stimulant 
0,532   0,034           CDK2/cyclin A inhibitor 
0,575   0,015           Lipid peroxidase inhibitor
0,797   0,005           Antioxidant 
0,533   0,042           NADPH-ferrihemoprotein reductase inhibitor
0,508   0,035           Dihydroxy-acid dehydratase inhibitor
0,482   0,010           Glutathione-disulfide reductase inhibitor 
0,558   0,096           Oxidoreductase inhibitor 
0,503   0,040           Kinase inhibitor 
0,857   0,014           Antineoplastic
0,727   0,023           Antifungal
0,543   0,094           Hydroxylamine reductase (NADH) inhibitor 
0,701   0,014           Hemostatic 
0,465   0,033           Scytalone dehydratase inhibitor 
0,508   0,082           Trans-cinnamate 4-monooxygenase inhibitor 
0,464   0,043           CYP2C11 substrate
0,488   0,068           Nitrite reductase [NAD(P)H] inhibitor 
0,498   0,080           Steroid N-acetylglucosaminyltransferase inhibitor 
0,446   0,049           Polarisation stimulant 
0,400   0,007           Histidine decarboxylase inhibitor 
0,797   0,005           Antipruritic, allergic 
0,425   0,034           Xenobiotic-transporting ATPase inhibitor 
0,449   0,059           Histamine release inhibitor 
0,394   0,005           CYP1B substrate 
0,370   0,005           CYP1B1 substrate
0,482   0,096           Trans-pentaprenyltranstransferase inhibitor 
0,416   0,031           Plastoquinol-plastocyanin reductase inhibitor
0,410   0,036           Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor
0,423   0,058           Vitamin-K-epoxide reductase (warfarin-insensitive) inhibitor 
0,379   0,017           Dihydrobenzophenanthridine oxidase inhibitor 
0,409   0,049           Trypanothione-disulfide reductase inhibitor
0,369   0,013           Quercetin 2,3-dioxygenase inhibitor 
0,440   0,084           CYP2B5 substrate 
0,564   0,010           Expectorant 
0,318   0,009           Mucolytic 
0,379   0,029           Flavone apiosyltransferase inhibitor
0,375   0,028           2-Enoate reductase inhibitor 
0,476   0,129           Cardiovascular analeptic
0,373   0,028           Myc inhibitor 
0,857   0,014           Antineoplastic 
0,517   0,172           Ecdysone 20-monooxygenase inhibitor 
0,438   0,097           Gonadotropin antagonist 
0,356   0,016           (S)-canadine synthase inhibitor 
0,387   0,050           L-lysine 6-transaminase inhibitor 
0,438   0,099           Membrane permeability enhancer 
0,727   0,023           Antifungal 
0,438   0,099           Cystic fibrosis treatment 
0,382   0,050           CYP2C6 substrate 
0,381   0,050           DNA ligase (ATP) inhibitor
0,380   0,053           Asparagine-tRNA ligase inhibitor 
0,442   0,115           Indole-3-acetaldehyde oxidase inhibitor
0,401   0,074           Cholestanetriol 26-monooxygenase inhibitor 
0,432   0,111           4-Methoxybenzoate monooxygenase (O-demethylating) inhibitor 
0,939   0,005           Antipruritic 
0,797   0,005           Antipruritic, allergic
0,426   0,114           CYP2A2 substrate 
0,333   0,025           Salutaridinol 7-O-acetyltransferase inhibitor 
0,439   0,132           Leukotriene C antagonist 
0,340   0,268           Leukotriene C4 antagonist 
0,406   0,100           2,6-Dihydroxypyridine 3-monooxygenase inhibitor 
0,371   0,067           Phenol 2-monooxygenase inhibitor 
0,402   0,098           CYP2B11 substrate 
0,507   0,109           Immunosuppressant 
0,939   0,005           Antiinflammatory 
0,797   0,005           Antipruritic, allergic 
0,371   0,071           CYP2A5 substrate 
0,331   0,030           Indoleamine-pyrrole 2,3-dioxygenase inhibitor 
0,375   0,075           CYP2F1 substrate 
0,374   0,074           Inositol 4-methyltransferase inhibitor 
0,398   0,099           Nitrate reductase inhibitor 
0,371   0,073           Thiamine-triphosphatase inhibitor
0,315   0,014           Tubulin antagonist 
0,857   0,014           Antineoplastic
0,315   0,014           Antileukemic 
0,312   0,015           Glycerol dehydrogenase (NADP+) inhibitor 
0,440   0,147           Adenylate cyclase stimulant 
0,694   0,083           Myocardial ischemia treatment
0,302   0,013           2-Dehydropantolactone reductase (A-specific) inhibitor 
0,326   0,038           Deoxyribonuclease I inhibitor 
0,314   0,026           CYP2A10 substrate
0,430   0,144           Proteasome endopeptidase complex inhibitor
0,322   0,035           3-Demethylubiquinone-9 3-O-methyltransferase inhibitor 
0,332   0,049           RNA synthesis inhibitor
0,857   0,014           Antineoplastic
0,684   0,026           6  Lipoxygenase inhibitor 
0,523   0,023           5 Lipoxygenase inhibitor 
0,939   0,005           Antiinflammatory 
0,797   0,005           Antipruritic, allergic
0,797   0,005           Antipsoriatic
0,939   0,005           Antiinflammatory 
0,332   0,069           Interferon antagonist
0,561   0,048           Imidazoline receptor agonist 
0,365   0,027           Imidazoline I1 receptor agonist
0,315   0,056           Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase inhibitor
0,331   0,074           Phloroglucinol reductase inhibitor 
0,387   0,131           L-glucuronate reductase inhibitor 
0,326   0,071           Fumarate reductase (NADH) inhibitor 
0,380   0,127           Alcohol oxidase inhibitor 
0,394   0,147           Thromboxane B2 antagonist 
0,304   0,061           Tetrahydroxynaphthalene reductase inhibitor 
0,306   0,067           Biphenyl-2,3-diol 1,2-dioxygenase inhibitor 
0,398   0,163           Neurotrophic factor
0,426   0,194           Peroxidase inhibitor 
0,382   0,155           Glucan 1,4-beta-glucosidase inhibitor
0,395   0,171           Cyclooxygenase 1 inhibitor 
0,303   0,079           AMP deaminase inhibitor 
0,363   0,137           Prostaglandin antagonist 
0,939   0,005           Antiinflammatory 
0,361   0,140           Chemoprotective
0,326   0,108           CYP3A substrate 
0,517   0,138           CYP3A1 substrate 
0,495   0,100           CYP3A2 substrate
0,352   0,106           CYP3A4 substrate
0,340   0,122           Gentisate 1,2-dioxygenase inhibitor
0,410   0,195           Tumour necrosis factor alpha antagonist 
0,939   0,005           Antiinflammatory 
0,394   0,179           Cathepsin G inhibitor 
0,384   0,172           Lactaldehyde reductase inhibitor 
0,392   0,181           Quinoprotein glucose dehydrogenase inhibitor
0,367   0,158           Interferon agonist 
0,857   0,014           Antineoplastic
0,319   0,118           Anthranilate 3-monooxygenase (deaminating) inhibitor 
0,377   0,182           Magnesium-
protoporphyrin IX monomethyl ester (oxidative) cyclase inhibitor 
0,341   0,152           H+-transporting two-sector ATPase inhibitor
0,399   0,213           CYP2D16 substrate
0,355   0,171           Pyruvate decarboxylase inhibitor 
0,391   0,218           CYP2A1 substrate 
0,306   0,139           Monoamine uptake inhibitor
0,386   0,221           Lipid metabolism regulator 
0,366   0,203           Penicillin amidase inhibitor
0,321   0,162           Octopamine antagonist 
0,316   0,161           Glutaminase inhibitor 
0,329   0,177           Glycerol-3-phosphate dehydrogenase inhibitor 
0,313   0,166           CYP2C8 substrate 
0,326   0,183           L-iditol 2-dehydrogenase inhibitor 
0,314   0,175           Microtubule formation stimulant 
0,311   0,177           CYP2B6 substrate 
0,308   0,212           Myosin ATPase inhibitor
0,333   0,243           ATPase inhibitor
0,771   0,048           Antiulcerative 
0,333   0,069           Antiosteoporotic 
0,360   0,277           Uroporphyrinogen-III synthase inhibitor 
0,319   0,245           Platelet adhesion inhibitor 
0,337   0,264           Vasodilator, cerebral 
0,311   0,240           CC chemokine 2 receptor antagonist
0,301   0,230           Laccase inhibitor 
0,306   0,236           Vomilenine glucosyltransferase inhibitor 
0,321   0,263           Membrane dipeptidase inhibitor 
0,329   0,289           2-Oxoglutarate decarboxylase inhibitor 
0,335   0,301           Glyceryl-ether monooxygenase inhibitor 
0,343   0,311           NADPH oxidase inhibitor
0,324   0,301           3-Hydroxybenzoate 4-monooxygenase inhibitor
0,322   0,299           Monodehydroascorbate reductase (NADH) inhibitor
0,335   0,316           Insulysin inhibitor 
0,321   0,304           Integrin antagonist 
0,939   0,005           Antiinflammatory
0,857   0,014           Antineoplastic 
0,333   0,069           Antiosteoporotic 
0,301   0,291           Gingipain K inhibitor
0,302   0,300           [acyl-carrier-protein] S-acetyltransferase inhibitor
0,327   0,328           General pump inhibitor
0,305   0,312           2,3-Dihydroxybenzoate 2,3-dioxygenase inhibitor
0,309   0,328           N-carbamoyl-L-amino-acid hydrolase inhibitor 








Table-4:Biological Activity Spectrum Of Anti HIV constituent - Cardamonin
28 Substructure descriptors; 0 new. 7 Possible activities at Pa > 70% Pa Pi for Activity:
0,899   0,014    Mucomembranous protector 
0,878   0,001    Sodium/bile acid cotransporter inhibitor
0,884   0,021    Membrane integrity agonist 
0,769   0,008    2,6-Dihydroxypyridine 3-monooxygenase inhibitor 
0,763   0,030    CC chemokine 2 receptor antagonist 
0,789   0,083    Antiseborrheic 
0,703   0,015    Carminative 
EFFECTS
0,884   0,021           Antiviral 
0,884   0,021           Antiviral (HIV)
0,884   0,021           Membrane integrity agonist 
0,884   0,021           Membrane integrity agonist 
0,884   0,021           Antipruritic 
0,884   0,021           Membrane integrity agonist 
0,884   0,021           Antiinflammatory 
0,884   0,021           Membrane integrity agonist 
0,763   0,030           Antineurogenic pain 
0,763   0,030           CC chemokine 2 receptor antagonist 
0,878   0,001           Atherosclerosis treatment 
0,878   0,001           Sodium/bile acid cotransporter inhibitor 
0,884   0,021           Dermatologic 
0,884   0,021           Antieczematic 
0,884   0,021           Membrane integrity agonist
0,884   0,021           Antiseborrheic 
0,884   0,021           Membrane integrity agonist 
0,884   0,021           Psychotropic 
0,884   0,021           Antiepileptic 
0,884   0,021           Membrane integrity agonist 
0,763   0,030           Antiarthritic 
0,763   0,030           CC chemokine 2 receptor antagonist 
0,878   0,001           Antihypercholesterolemic 
0,878   0,001            Sodium/bile acid cotransporter inhibitor 
0,000   0,000           Antiulcerative
0,899   0,014           Mucomembranous protector 
MECHANISMS
0,899   0,014           Mucomembranous protector 
0,878   0,001           Sodium/bile acid cotransporter inhibitor
0,884   0,021           Membrane integrity agonist 
0,884   0,021           Antiseborrheic 
0,769   0,008           2,6-Dihydroxypyridine 3-monooxygenase inhibitor 
0,763   0,030           CC chemokine 2 receptor antagonist 
 
 
 
